Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107,809,066
-
Total 13F shares
-
56,360,007
-
Share change
-
+2,531,425
-
Total reported value
-
$1,122,649,782
-
Put/Call ratio
-
60%
-
Price per share
-
$19.88
-
Number of holders
-
158
-
Value change
-
+$49,243,199
-
Number of buys
-
88
-
Number of sells
-
56
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q3 2020
As of 30 Sep 2020,
Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
56,360,007 shares.
The largest 10 holders included
ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Chevy Chase Trust Holdings, Inc., Atlas Venture Associates IX, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and FMR LLC.
This page lists
159
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.